STRATEGY STUDIO / PUBLIC DATA EXPLORER

ACCESS TO ADVANCED HEALTH INSTITUTE: Form 990, tax year 2022

View the entire original 990 at ProPublica ↗

Organization
ACCESS TO ADVANCED HEALTH INSTITUTE (EIN 91-1608978)
Tax period
2022-01-01 to 2022-12-31
Filed
2023-11-15
IRS object ID
202333199349317753
Schema version
2022v5.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2023-11-15T14:22:14-06:00ReturnTs
Tax Period End2022-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN911194016PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1CLARK NUBER PSBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line110900 NE 4TH STREET SUITE 1400AddressLine1Txt
CityBELLEVUECityNm
State AbbreviationWAStateAbbreviationCd
ZIP98004ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2022-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN911608978EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1ACCESS TO ADVANCED HEALTH INSTITUTEBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlACCEBusinessNameControlTxt
Phone2063810883PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11616 EASTLAKE AVE E 400AddressLine1Txt
CitySEATTLECityNm
State AbbreviationWAStateAbbreviationCd
ZIP98102ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonJERRY KUOPersonNm
Person TitleCOO & CFOPersonTitleTxt
Phone2063810883PhoneNum
Signature2023-11-14SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstJERRYPersonFirstNm
Person LastKUOPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN
FieldValueIRS element (for citing)
IRS Responsible Prty Info Curr0IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonMEGAN R RYANPreparerPersonNm
PTINP00737884PTIN
Phone4254544919PhoneNum
Preparation2023-11-14PreparationDt

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer2TrustedCustomerCd
Authentication Assurance LevelAAL1AuthenticationAssuranceLevelCd
Identity Assurance LevelIAL1IdentityAssuranceLevelCd
FieldValueIRS element (for citing)
Tax2022TaxYr
Build TS2023-04-26 12:10:37ZBuildTS

Form 990 IRS990

Doing Business As Name DoingBusinessAsName

FieldValueIRS element (for citing)
Business Name Line1INFECTIOUS DISEASE RESEARCH INSTITUTEBusinessNameLine1Txt
FieldValueIRS element (for citing)
Principal OfficerJERRY KUOPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line11616 EASTLAKE AVE E 400AddressLine1Txt
CitySEATTLECityNm
State AbbreviationWAStateAbbreviationCd
ZIP98102ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$51,810,699GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.AAHI.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1993FormationYr
Legal Domicile StateWALegalDomicileStateCd
Activity Or MissionDEVELOP VACCINES, ADJUVANTS, DIAGNOSTICS & DRUGS TO PREVENT, DETECT & TREAT INFECTIOUS DISEASES OF GLOBAL IMPORTANCE.ActivityOrMissionDesc
Voting Members Governing Body7VotingMembersGoverningBodyCnt
Voting Members Independent5VotingMembersIndependentCnt
Total Employee79TotalEmployeeCnt
Total Volunteers5TotalVolunteersCnt
Total Gross UBI$30,750TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$15,171NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$6,701,932PYContributionsGrantsAmt
CY Contributions Grants$33,420,108CYContributionsGrantsAmt
PY Program Service Revenue$12,880,960PYProgramServiceRevenueAmt
CY Program Service Revenue$17,386,494CYProgramServiceRevenueAmt
PY Investment Income$2,746PYInvestmentIncomeAmt
CY Investment Income$61,987CYInvestmentIncomeAmt
PY Other Revenue$5,672,516PYOtherRevenueAmt
CY Other Revenue$317,665CYOtherRevenueAmt
PY Total Revenue$25,258,154PYTotalRevenueAmt
CY Total Revenue$51,186,254CYTotalRevenueAmt
PY Grants And Similar Paid$0PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$0CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$7,522,915PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$9,652,019CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$14,774,847PYOtherExpensesAmt
CY Other Expenses$11,710,438CYOtherExpensesAmt
PY Total Expenses$22,297,762PYTotalExpensesAmt
CY Total Expenses$21,362,457CYTotalExpensesAmt
PY Revenues Less Expenses$2,960,392PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$29,823,797CYRevenuesLessExpensesAmt
Total Assets BOY$16,228,599TotalAssetsBOYAmt
Total Assets EOY$42,840,477TotalAssetsEOYAmt
Total Liabilities BOY$19,979,338TotalLiabilitiesBOYAmt
Total Liabilities EOY$16,927,712TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY-$3,750,739NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$25,912,765NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionAAHI IS A NONPROFIT BIOTECH RESEARCH INSTITUTE, BRINGING TOGETHER THE BEST EXPERTS, TECHNOLOGIES, AND PLATFORMS TO CREATE ACCESSIBLE, HIGH-QUALITY PRODUCTS AND SOLUTIONS FOR HARNESSING THE IMMUNE SYSTEM TO ALLEVIATE DISEASE.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$4,430,705ExpenseAmt
Revenue$7,821,670RevenueAmt
DescRNA VACCINES - RNA VACCINES HAVE BEEN SHOWN TO BE CRITICAL TOOLS FOR COMBATTING PANDEMICS AND HAVE BEEN SAFELY ADMINISTERED TO BILLIONS OF PEOPLE ACROSS THE GLOBE. AAHI'S RNA VACCINE PLATFORM IS DISTINCT FROM EXISTING LICENSED RNA VACCINES IN THAT IT IS BASED ON A SELF-AMPLIFYING RNA TECHNOLOGY AND DELIVERED BY A FLEXIBLE NANOSTRUCTURED LIPID CARRIER. TOGETHER, THESE FEATURES MEAN THAT THE VACCINE COULD BE STOCKPILED FOR YEARS, DELIVERED AT ROOM TEMPERATURE, AND MORE RAPIDLY MANUFACTURED TO ADDRESS FUTURE PANDEMICS. AAHI SCIENTISTS ARE ADVANCING RNA VACCINES AGAINST COVID-19, INFLUENZA, YELLOW FEVER, ZIKA, CHIKUNGUNYA, AND HIV, AND ADAPTING THE PLATFORM TO BE DELIVERED BY NASAL SPRAY OR DIRECTLY ADMINISTERED INTO TUMORS.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$4,260,904ExpenseAmt
Revenue$3,135,348RevenueAmt
DescFORMULATIONS - ADJUVANTS ARE POWERFUL IMMUNE-STIMULATING MOLECULES THAT INCREASE THE EFFICACY OF VACCINES AND ENHANCE THE IMMUNE SYSTEM'S ABILITY TO DESTROY TUMORS. AAHI HAS AMONG THE LARGEST PORFOLIOS OF ADJUVANTS; IMPORTANTLY, AAHI SCIENTISTS FORMULATE THESE MOLECULES IN A WAY THAT MAKES THEM MINIMALLY TOXIC AND MAXIMALLY POTENT. IN PARTNERSHIP WITH VACCINE DEVELOPERS ACROSS THE WORLD, MANY AAHI ADJUVANT FORMULATIONS HAVE BEEN SAFELY ADMINISTERED TO THOUSANDS OF PEOPLE IN RIGOROUS CLINICAL TRIALS. AAHI'S ADJUVANT FORMULATIONS NOW ARE IN LEADING VACCINE CANDIDATES AGAINST HIV, TUBERCULOSIS, MALARIA, AND A MYRIAD OF OTHER INFECTIOUS DISEASES.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$3,238,592ExpenseAmt
Revenue$6,374,400RevenueAmt
DescMANUFACTURING AND CLINICAL SUPPORT - AAHI'S IN-HOUSE MANUFACTURING CAPABILITIES SUPPORT RAPID SCALE-UP AND PRODUCTION OF VACCINES FOR USE IN PHASE 1 AND PHASE 2 CLINICAL TRIALS AND COMPLETE AAHIS'S UNIQUE VACCINE DISCOVERY-DEVELOPMENT PROCESS. AAHI'S RESEARCH SCIENTISTS AND FORMULATIONS/PROCESS DEVELOPMENT TEAMS WORK WITH AAHI'S MANUFACTURING EXPERTS TO DEVELOP MANUFACTURING PROCESSES TO PRODUCE VACCINE CANDIDATES UNDER CONTROLLED CONDITIONS SO THAT THEY ARE SUITABLE FOR USE IN HUMAN STUDIES. THIS ENABLES AAHI TO QUICKLY AND EFFICIENTLY MOVE A VACCINE FROM LATE-STAGE RESEARCH TO EARLY PHASE CLINICAL STUDIES. AAHI CONSULTS LATER STAGE CLINICAL STUDIES. AAHI'S MANUFACTURING SUITE FOLLOWS US FDA "GOOD MANUFACTURING PRACTICE" REGULATIONS AND IS AN INVALUABLE RESOURCE TO AAHI SCIENTISTS AND BIOTECHNOLOGY DEVELOPERS IN THE NON-PROFIT, ACADEMIC, AND FOR-PROFIT SECTORS.Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

FieldValueIRS element (for citing)
Expense$152,443ExpenseAmt
Revenue$55,076RevenueAmt
DescPROCESS AND PRODUCT DEVELOPMENT - MODERN VACCINES ARE INCREASINGLY COMPLEX AND THEIR DESIGN NEEDS TO BE TAILORED TO SPECIFIC TARGET PRODUCT PROFILES TO ENSURE PRACTICAL ACCESSIBILITY. SUSTAINABLE SOURCING OF RAW MATERIALS, STREAMLINED MANUFACTURING METHODS, AND TEMPERATURE STABILITY ARE CRITICALLY IMPORTANT TO ENABLE VACCINES FOR GLOBAL HEALTH APPLICATIONS IN RESOURCE-LIMITED SETTINGS. ALTERNATIVE ROUTES OF ADMINISTRATION, SUCH AS INTRANASAL DELIVERY, NOT ONLY MAY BEST BE SUITED TO FIGHT RESPIRATORY PATHOGENS BUT ALSO HELP TO ADDRESS VACCINE HESITANCY AND TO INCREASE VACCINE UPTAKE. AAHI SCIENTISTS ARE WORLD-EXPERTS AT DEVELOPING PROCESSES AND METHODS TO ADVANCE NOVEL PRODUCTS THAT MEET THE NEEDS OF VACCINE DEVELOPERS BOTH WITHIN AAHI AND EXTERNALLY AMONG THE DOZENS OF ACADEMIC, NON-PROFIT, AND COMMERCIAL PARTNERS.Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$152,443TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Revenue$55,076TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$12,082,644TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other AssetsYes (1)ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To Organizations0GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl EntYes (1)BusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (1)DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded EntityYes (1)DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document32IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Employee79EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (1)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (1)Form990TFiledInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Form8899 Filedind1Form8899Filedind
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members7GoverningBodyVotingMembersCnt
Independent Voting Member5IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org DocumentsYes (1)ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn Body0Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc0RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonSUZAN SNODGRASSPersonNm
Phone2068586025PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11616 EASTLAKE AVE E SUITE 400AddressLine1Txt
CitySEATTLECityNm
State AbbreviationWAStateAbbreviationCd
ZIP98102ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (24 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
COREY CASPER
CEO, PRESIDENT40.00Yes (X)Yes (X)$626,233$0$33,881
SHELLY CROCKER
RECEIVER THRU 02/2240.00Yes (X)$0$0$0
PATRICK SOON-SHIONG
BOARD MEMBER0.50Yes (X)$0$0$0
DAVID KERR
BOARD MEMBER0.50Yes (X)$0$0$0
EDWARD MOCARSKI
BOARD MEMBER0.50Yes (X)$0$0$0
EDWARD HSU
BOARD MEMBER0.50Yes (X)$0$0$0
GLENDA GRAY
BOARD MEMBER0.50Yes (X)$0$0$0
RAOUL CONCEPCION
BOARD MEMBER0.50Yes (X)$0$0$0
JERRY KUO
COO & CFO, TREASURER40.00Yes (X)$336,867$0$41,555
CANDICE DECAIRE
CHIEF STRATEGY OFFICER, SECRETARY40.00Yes (X)$333,957$0$30,338
ANNA MARIE BECKMANN
EVP, PRODUCT DEVELOPMENT40.00$273,578$0$35,556Yes (X)
CHRISTOPHER FOX
SENIOR VP OF FORMULATIONS32.00$252,186$0$46,526Yes (X)
LINDA HAWKINS
DIR. QUALITY ASSURANCE40.00$196,618$0$33,642Yes (X)
ROBRICK SMITH
DIR. INFORMATION TECHNOLOGY40.00$191,231$0$36,622Yes (X)
DARREN KLEMKOW
DIR. FACILITIES & PROCUREMENT40.00$161,337$0$30,284Yes (X)
ALAN LEW
SENIOR CLINICAL TRIAL MANAGER40.00$164,664$0$21,066Yes (X)
LISA MCNEILL
DIR. MANUFACTURING40.00$160,719$0$19,786Yes (X)
JEFFREY GUDERIAN
DIR. LABORATORY MANAGEMENT40.00$151,752$0$26,407Yes (X)
HARNIK GULATI
DIR. PROJECT MANAGEMENT40.00$152,224$0$17,955Yes (X)
EMILY VOIGT
PRINCIPAL SCIENTIST40.00$147,121$0$37,150Yes (X)
ZACHARY SAGAWA
DIR. CLINICAL RESEARCH & REG. AFFAIRS40.00$141,190$0$31,325Yes (X)
JOHN ARGERIOUS
ASSOCIATE DIRECTOR, BUSINESS ADMIN40.00$129,738$0$26,833Yes (X)
DAMON PANG
CORPORATE COUNSEL40.00$129,630$0$26,800Yes (X)
LISA BOUCHARD
DIR. QUALITY CONTROL36.00$128,590$0$22,109Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$3,677,635TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$517,835TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K24IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
DANIEL J EDELMAN INC
21992 NETWORK PLACECHICAGOIL606731219STRATEGY CONSULTANTS$411,272
NEWPORT IP LLC
1400 112TH AVE SE SUITE 100BELLEVUEWA98004LEGAL$227,391
THE PETRIZZO GROUP INC
601 NEW JERSEY AVENUE NW STE 830WASHINGTONDC20001STRATEGY CONSULTANTS$180,000
CAIRNCROSS & HEMPELMANN
524 SECOND AVENUE SUITE 500SEATTLEWA98104LEGAL$170,116
LYOPHILIZATION TECHNOLOGY INC
30 INDIAN DRIVEIVYLANDPA18974DEVELOPMENT SCIENCES$166,733
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K11CntrctRcvdGreaterThan100KCnt
Government Grants$6,074,232GovernmentGrantsAmt
All Other Contributions$27,345,876AllOtherContributionsAmt
Noncash Contributions$1,042,300NoncashContributionsAmt
Total Contributions$33,420,108TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
SERVICES AND CONTRACTS541700$12,694,920$12,694,920
LICENSING541700$4,691,574$4,691,574
FieldValueIRS element (for citing)
Total Program Service Revenue$17,386,494TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$43,387TotalRevenueColumnAmt
Exclusion$43,387ExclusionAmt

Gross Rents GrossRentsGrp

FieldValueIRS element (for citing)
Real$820,481RealAmt

Less Rental Expenses LessRentalExpensesGrp

FieldValueIRS element (for citing)
Real$624,445RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$196,036RealAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$196,036TotalRevenueColumnAmt
Unrelated Business Revenue$30,750UnrelatedBusinessRevenueAmt
Exclusion$165,286ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Other$18,600OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Other$0OtherAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Other$18,600OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$18,600TotalRevenueColumnAmt
Exclusion$18,600ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtExclusionExclusionAmt
LITIGATION SETTLEMENT900099$100,000$100,000
PATENT FEES REIMB.900099$13,393$13,393
REFUNDS900099$7,435$7,435

Miscellaneous Revenue MiscellaneousRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$801TotalRevenueColumnAmt
Exclusion$801ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$121,629OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$51,186,254TotalRevenueColumnAmt
Related Or Exempt Func Income$17,386,494RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$30,750UnrelatedBusinessRevenueAmt
Exclusion$348,902ExclusionAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$3,400,903TotalAmt
Program Services$1,382,499ProgramServicesAmt
Management And General$2,018,404ManagementAndGeneralAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$4,863,246TotalAmt
Program Services$2,719,742ProgramServicesAmt
Management And General$2,143,504ManagementAndGeneralAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$175,111TotalAmt
Program Services$88,488ProgramServicesAmt
Management And General$86,623ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$602,935TotalAmt
Program Services$299,680ProgramServicesAmt
Management And General$303,255ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$609,824TotalAmt
Program Services$303,014ProgramServicesAmt
Management And General$306,810ManagementAndGeneralAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$808,600TotalAmt
Program Services$99,646ProgramServicesAmt
Management And General$708,954ManagementAndGeneralAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$603,926TotalAmt
Management And General$603,926ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$238,612TotalAmt
Management And General$238,612ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$1,082,828TotalAmt
Program Services$1,078,428ProgramServicesAmt
Management And General$4,400ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$163,992TotalAmt
Program Services$71,140ProgramServicesAmt
Management And General$92,852ManagementAndGeneralAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$383,841TotalAmt
Management And General$383,841ManagementAndGeneralAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$164,387TotalAmt
Management And General$164,387ManagementAndGeneralAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$2,092,143TotalAmt
Program Services$1,598,594ProgramServicesAmt
Management And General$493,549ManagementAndGeneralAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$61,452TotalAmt
Program Services$3,421ProgramServicesAmt
Management And General$58,031ManagementAndGeneralAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$9,160TotalAmt
Program Services$1,400ProgramServicesAmt
Management And General$7,760ManagementAndGeneralAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$1,499,826TotalAmt
Program Services$750,977ProgramServicesAmt
Management And General$748,849ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$159,036TotalAmt
Management And General$159,036ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmt
SUBCONTRACTS$2,202,675$2,202,675
LAB SUPPLIES$1,359,958$1,184,033$175,925
REPAIRS & MAINTENANCE$366,981$226,946$140,035
BAD DEBT$200,000$200,000

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$313,021TotalAmt
Program Services$71,961ProgramServicesAmt
Management And General$241,060ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$21,362,457TotalAmt
Program Services$12,082,644ProgramServicesAmt
Management And General$9,279,813ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$1,775,321BOYAmt
EOY$5,799,234EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$3,926,335BOYAmt
EOY$1,116,207EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$16,839,707EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$3,819,586BOYAmt
EOY$4,108,085EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$403,319BOYAmt
EOY$746,871EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$117,856BOYAmt
EOY$651,552EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$20,838,047LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$15,215,811LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$6,089,828BOYAmt
EOY$5,622,236EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$96,354BOYAmt
EOY$1,090,104EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$6,866,481EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$16,228,599BOYAmt
EOY$42,840,477EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$2,806,166BOYAmt
EOY$1,566,507EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$5,299,953BOYAmt
EOY$2,788,673EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$1,925,000BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$9,948,219BOYAmt
EOY$12,572,532EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$19,979,338BOYAmt
EOY$16,927,712EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY-$3,750,739BOYAmt
EOY$9,076,058EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$16,836,707EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY-$3,750,739BOYAmt
EOY$25,912,765EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$16,228,599BOYAmt
EOY$42,840,477EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$29,823,797ReconcilationRevenueExpnssAmt
Other Changes In Net Assets-$160,293OtherChangesInNetAssetsAmt
Info In Schedule O Part XIIYes (X)InfoInScheduleOPartXIIInd
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit RequiredYes (1)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (1)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$14,143,765CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$11,251,999CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$3,584,439CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$6,701,932CurrentTaxYearMinus1YearAmt
Current Tax Year$33,420,108CurrentTaxYearAmt
Total$69,102,243TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$14,143,765CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$11,251,999CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$3,584,439CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$6,701,932CurrentTaxYearMinus1YearAmt
Current Tax Year$33,420,108CurrentTaxYearAmt
Total$69,102,243TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$26,000,959SubstantialContributorsTotAmt
Public Support Total170$43,101,284PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$45,438CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$13,436CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$532CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$622,450CurrentTaxYearMinus1YearAmt
Current Tax Year$833,118CurrentTaxYearAmt
Total$1,514,974TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus1 Year$12,382CurrentTaxYearMinus1YearAmt
Current Tax Year$15,171CurrentTaxYearAmt
Total$27,553TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years-$536CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years-$13CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$193,881CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$5,587,477CurrentTaxYearMinus1YearAmt
Current Tax Year$121,629CurrentTaxYearAmt
Total$5,902,438TotalAmt
FieldValueIRS element (for citing)
Total Support$76,547,208TotalSupportAmt
Gross Receipts Rltd Activities$65,900,532GrossReceiptsRltdActivitiesAmt
Public Support CY1700.56310PublicSupportCY170Pct
Public Support PY1700.81660PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME:FormAndLineReferenceDesc
ExplanationMISCELLANEOUS - 2020 AMOUNT: $ 5,857. 2021 AMOUNT: $ 13,195. 2022 AMOUNT: $ 801. REIMBURSEMENTS - 2020 AMOUNT: $ 121,334. 2021 AMOUNT: $ 22,534. 2022 AMOUNT: $ 13,393. CURRENCY EXCHANGE - 2018 AMOUNT: $ -536. 2019 AMOUNT: $ -13. REFUNDS - 2020 AMOUNT: $ 66,690. 2021 AMOUNT: $ 19,248. 2022 AMOUNT: $ 7,435. LITIGATION SETTLEMENT - 2021 AMOUNT: $ 5,532,500. 2022 AMOUNT: $ 100,000.ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$11,377,971OtherCostOrOtherBasisAmt
Depreciation$7,403,575DepreciationAmt
Book Value$3,974,396BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$9,460,076OtherCostOrOtherBasisAmt
Depreciation$7,812,236DepreciationAmt
Book Value$1,647,840BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$5,622,236TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp

FieldValueIRS element (for citing)
DescRIGHT-OF-USE ASSETDesc
Book Value$6,866,481BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Other Assets$6,866,481TotalBookValueOtherAssetsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescOPERATING LEASE LIABILITYDesc
Amt$12,572,532Amt
FieldValueIRS element (for citing)
Total Liability$12,572,532TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt$51,467,419TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst-$160,293NetUnrealizedGainsInvstAmt
Other Revenue-$164,387OtherRevenueAmt
Revenue Not Reported-$324,680RevenueNotReportedAmt
Revenue Subtotal$51,792,099RevenueSubtotalAmt
Other Revenues Not Included-$605,845OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt-$605,845RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$51,186,254TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$21,803,915TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$605,845OtherExpensesIncludedAmt
Expenses Not Reported$605,845ExpensesNotReportedAmt
Expenses Subtotal$21,198,070ExpensesSubtotalAmt
Other Expenses Not Included$164,387OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$164,387ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$21,362,457TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART XI, LINE 2D - OTHER ADJUSTMENTS:ROYALTIES EXPENSE REPORTED ON PART IX -164,387.
PART XI, LINE 4B - OTHER ADJUSTMENTS:GAIN/LOSS ON SALE OF ASSET REPORTED ON PART VIII 18,600. SUBLEASE EXPENSE REPORTED ON PART VIII -624,445.
PART XII, LINE 2D - OTHER ADJUSTMENTS:GAIN/LOSS ON SALE OF ASSET REPORTED ON PART VIII -18,600. SUBLEASE EXPENSE REPORTED ON PART VIII 624,445.
PART XII, LINE 4B - OTHER ADJUSTMENTS:ROYALTIES EXPENSE REPORTED ON PART IX 164,387.

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (10 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
EAST ASIA AND THE PACIFIC00LEGALN/A$39,560
EUROPE (INCLUDING ICELAND & GREENLAND)00LEGALN/A$74,203
EUROPE (INCLUDING ICELAND & GREENLAND)00PROGRAM SERVICESUBCONTRACT, SUPPLIES, SOFTWARE$255,453
MIDDLE EAST AND NORTH AFRICA00LEGALN/A$9,628
NORTH AMERICA00PROGRAM SERVICESUBCONTRACT, SUPPLIES$207,956
NORTH AMERICA00LEGALN/A$8,233
RUSSIA AND NEIGHBORING STATES00LEGALN/A$2,367
SOUTH AMERICA00LEGALN/A$11,687
SOUTH ASIA00LEGALN/A$32,410
SUB-SAHARAN AFRICA00LEGALN/A$3,514
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$609,087SubtotalSpentAmt
Continuation Spent$35,924ContinuationSpentAmt
Total Spent$645,011TotalSpentAmt
Transfer To Foreign CorpYes (1)TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART III ACCOUNTING METHOD:
SCHEDULE F, PART IV, LINE 1:FORM 926 IS NOT REQUIRED TO BE FILED BECAUSE THE TRANSFER TO A FOREIGN CORPORATION DOES NOT MEET THE REPORTING REQUIREMENTS IN THE IRC SEC. 6038(A)(1)(A).

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Substantiation RequiredYes (1)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (1)AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (17 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
COREY CASPER
CEO, PRESIDENT$525,375$0$44,625$0$56,233$0$8,612$0$25,269$0$660,114$0$0$0
JERRY KUO
COO & CFO, TREASURER$334,867$0$0$0$2,000$0$10,652$0$30,903$0$378,422$0$0$0
CANDICE DECAIRE
CHIEF STRATEGY OFFICER, SECRETARY$331,957$0$0$0$2,000$0$10,414$0$19,924$0$364,295$0$0$0
ANNA MARIE BECKMANN
EVP, PRODUCT DEVELOPMENT$261,785$0$11,588$0$205$0$10,945$0$24,611$0$309,134$0$0$0
CHRISTOPHER FOX
SENIOR VP OF FORMULATIONS$192,868$0$59,113$0$205$0$10,305$0$36,221$0$298,712$0$0$0
LINDA HAWKINS
DIR. QUALITY ASSURANCE$188,004$0$8,411$0$203$0$8,025$0$25,617$0$230,260$0$0$0
ROBRICK SMITH
DIR. INFORMATION TECHNOLOGY$182,842$0$8,186$0$203$0$5,858$0$30,764$0$227,853$0$0$0
DARREN KLEMKOW
DIR. FACILITIES & PROCUREMENT$154,384$0$6,750$0$203$0$6,568$0$23,716$0$191,621$0$0$0
ALAN LEW
SENIOR CLINICAL TRIAL MANAGER$157,508$0$6,953$0$203$0$6,677$0$14,389$0$185,730$0$0$0
EMILY VOIGT
PRINCIPAL SCIENTIST$140,865$0$6,048$0$208$0$6,345$0$30,805$0$184,271$0$0$0
LISA MCNEILL
DIR. MANUFACTURING$153,818$0$6,698$0$203$0$6,475$0$13,311$0$180,505$0$0$0
JEFFREY GUDERIAN
DIR. LABORATORY MANAGEMENT$145,069$0$6,480$0$203$0$2,518$0$23,889$0$178,159$0$0$0
ZACHARY SAGAWA
DIR. CLINICAL RESEARCH & REG. AFFAIR$134,943$0$6,030$0$217$0$5,588$0$25,737$0$172,515$0$0$0
HARNIK GULATI
DIR. PROJECT MANAGEMENT$145,532$0$6,489$0$203$0$5,448$0$12,507$0$170,179$0$0$0
JOHN ARGERIOUS
ASSOCIATE DIRECTOR, BUSINESS ADMIN$123,958$0$5,562$0$218$0$5,307$0$21,526$0$156,571$0$0$0
DAMON PANG
CORPORATE COUNSEL$123,787$0$5,625$0$218$0$5,473$0$21,327$0$156,430$0$0$0
LISA BOUCHARD
DIR. QUALITY CONTROL$127,922$0$450$0$218$0$5,312$0$16,797$0$150,699$0$0$0

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 1BTHE CEO APPROVED THE PROVISION OF THIS BENEFIT.
PART I, LINE 7BONUS AMOUNTS FOR THE EXECUTIVE TEAM ARE DETERMINED BY THE BOARD OF DIRECTORS. THE EXECUTIVE DETERMINES BONUS AMOUNTS FOR ALL OTHER STAFF.

Schedule L IRS990ScheduleL

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp

Name Of Interested NameOfInterested

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1IMMUNITY BIOBusinessNameLine1Txt
FieldValueIRS element (for citing)
Relationship DescriptionBOARD MEMBER >35% OWNER OF THE ORGANIZATIONRelationshipDescriptionTxt
Transaction$6,009,977TransactionAmt
TransactionANNUAL LICENSING AGREEMENT, CONTRACT SERVICES, PRODUCT & MATERIALS PROCEEDSTransactionDesc
Sharing Of Revenues0SharingOfRevenuesInd

Schedule M IRS990ScheduleM

Secur Prtnrshp Trust Intrsts SecurPrtnrshpTrustIntrstsGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution1ContributionCnt
Noncash Contributions Rpt F990$1,000,000NoncashContributionsRptF990Amt
Method Of Determining RevenuesFAIR MARKET VALUATIONMethodOfDeterminingRevenuesTxt

Other Non Cash Contri Table OtherNonCashContriTableGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
DescLAB EQUIPMENTDesc
Contribution6ContributionCnt
Noncash Contributions Rpt F990$42,300NoncashContributionsRptF990Amt
Method Of Determining RevenuesCOSTMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Form8283 Received0Form8283ReceivedCnt
Any Property That Must Be Held0AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts0ReviewProcessUnusualNCGiftsInd
Third Parties Used0ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, COLUMN (B):FormAndLineReferenceDesc
ExplanationTHE AMOUNT IN COLUMN (B) REPRESENTS THE NUMBER OF ITEMS RECEIVED.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (7 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART I, LINE 6:ACCESS TO ADVANCED HEALTH INSTITUTE HAD FIVE VOLUNTEER BOARD MEMBERS IN 2022.
FORM 990, PART VI, SECTION A, LINE 4THE ORGANIZATION CAME OUT OF RECEIVERSHIP IN FEBRUARY OF 2022. THE ORGANIZATION FORMALLY CHANGED IT'S NAME AND DRAFTED AND APPROVED NEW GOVERNING DOCUMENTS INCLUDING ARTICLES OF INCORPORATON AND BYLAWS.
FORM 990, PART VI, SECTION B, LINE 11BA DRAFT OF THE FORM 990 IS REVIEWED BY THE COO & CFO AND DIRECTOR OF FINANCE. IN ADDITION, THE CHAIR OF THE FINANCE AND AUDIT COMMITTEE WILL REVIEW PRIOR TO FILING.
FORM 990, PART VI, SECTION B, LINE 15THE BOARD ESTABLISHED A COMPENSATION COMMITTEE AND A COMPENSATION POLICY. COMPENSATION FOR THE CEO IS REVIEWED AND SET BY THE BOARD AFTER REVIEWING KEY PERFORMANCE INDICATORS FOR THE ORGANIZATION. THE CEO REVIEWS AND SETS THE WAGES TO THE OTHER EXECUTIVE TEAM MEMBERS.
FORM 990, PART VI, SECTION C, LINE 19REQUESTS FOR INFORMATION SUCH AS AUDITED FINANCIAL STATEMENTS, GOVERNING DOCUMENTS, AND CONFLICT OF INTEREST POLICY ARE HANDLED THROUGH OUR FINANCE DEPARTMENT AND INFORMATION IS DISTRIBUTED AS REQUESTED UNLESS CONFIDENTIAL IN NATURE.
FORM 990, PART XI, LINE 9:PRESENT VALUE ADJUSTMENT TO PLEDGE RECEIVABLE -160,293.
FORM 990, PART XII, LINE 2C:THE ORGANIZATION EXITED RECEIVERSHIP AND FORMED A BOARD AND FINANCE AND AUDIT COMMITTEE.

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1TIGER DEVELOPMENT LLCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line13800 N CENTRAL AVE 460AddressLine1Txt
CityPHOENIXCityNm
State AbbreviationAZStateAbbreviationCd
ZIP85010ZIPCd
FieldValueIRS element (for citing)
Primary ActivitiesPATENT HOLDING COMPANYPrimaryActivitiesTxt
Legal Domicile StateAZLegalDomicileStateCd
Total Income$0TotalIncomeAmt
End Of Year Assets$1,000,000EndOfYearAssetsAmt

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1ACCESS TO ADVANCED HEALTH INSTITUTEBusinessNameLine1Txt